latest news on glp 1 A wave of new #GLP1 drug options for type 2 #Diabetes and #Obesity was a major focus at #ADA2026. In the JAMA Medical podcast, Jennifer Abbasi interviews Rita Kalyani, MD, New warning issued over compounded
Description
Dulaglutide (100 nM) augmented the phosphorylation state of phospholamban at serine 16 and the phosphorylation state of the inhibitory subunit of troponin
These label expansions unlocked new pathways for coverage, and by early 2025 the proportion of Medicare patients with diabetes or obesity initiating GLP-1 therapy rose sharply
Store Pick-Up or Delivery!
Get the skinny on Ozempic, Wegovy and more.
El uso de medicamentos GLP-1 como semaglutida para bajar de peso se ha duplicado en la ltima dcada, pero su uso ha disminuido entre los diabticos tipo 2, segn un nuevo estudio.
